[1]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62-65.[doi:10.3969/j.issn.1006-1959.2019.22.020]
　HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Journal of Medical Information,2019,32(22):62-65.[doi:10.3969/j.issn.1006-1959.2019.22.020]
点击复制

生物信息学分析筛选肺腺癌靶基因及评估预后的价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
62-65
栏目:
论著
出版日期:
2019-11-15

文章信息/Info

Title:
Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value
文章编号:
1006-1959（2019）22-0062-04
作者:
黄琪峰1; 郑琳琳2; 张 菁1
（浙江大学医学院附属邵逸夫医院药学部1，超声科2，浙江 杭州 310000）
Author(s):
HUANG Qi-feng1; ZHENG Lin-lin2; ZHANG Jing1
(Department of Pharmacy1,Department of Ultrasound2,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou 310000,Zhejiang,China)
关键词:
肺腺癌; 差异表达基因; 生物标志物; 生物信息学分析
Keywords:
Lung adenocarcinoma; Differentially expressed genes; Biomarkers; Bioinformatics analysis
分类号:
R734.2
DOI:
10.3969/j.issn.1006-1959.2019.22.020
文献标志码:
A
摘要:
目的 基于生物信息学分析筛选肺腺癌靶基因及评估预后价值。方法 对三个数据集（GSE118370、GSE32863、TCGA-LUAD）分别使用limma和edgeR包筛选出肺腺癌差异表达基因，对共同差异基因进行功能富集分析，通过String数据库构建蛋白质-蛋白质相互作用（PPI）网络，采用Cytoscape进行可视化分析并用其插件cytoHubba来筛选关键基因，采用Kaplan-Meier曲线进行总体生存分析。结果 共224个共同差异基因，其中上调基因34个，下调基因190个。共同差异基因在血管生成、白细胞调节、免疫反应等生物学过程富集。通过从PPI网络中筛选出8个关键基因，分别为IL6、VWF、PECAM1、SPP1、CDH5、CXCL12、TIMP1、CLDN5。生存分析显示，PECAM1与LUAD的预后有关。肿瘤组织中PECAM1表达高于正常组织，差异有统计学意义（P＜0.05）。结论 PECAM1是一种与肺腺癌预后相关的新的生物标志物，有望成为肺腺癌的一个治疗的靶点。
Abstract:
Objective To screen the target genes of lung adenocarcinoma based on bioinformatics analysis and evaluate the prognostic value. Methods Three data sets (GSE118370, GSE32863, TCGA-LUAD) were used to screen differentially expressed genes in lung adenocarcinoma using limma and edgeR packages, functional enrichment analysis of common differential genes, and protein-protein interactions were constructed by String database. PPI) network, using Cytoscape for visual analysis and using its plug-in cytoHubba to screen key genes, Kaplan-Meier curve for overall survival analysis. Results A total of 224 common differential genes, including 34 up-regulated genes and 190 down-regulated genes. Common differential genes are enriched in biological processes such as angiogenesis, leukocyte regulation, and immune response. Eight key genes were screened from the PPI network, namely IL6, VWF, PECAM1, SPP1, CDH5, CXCL12, TIMP1, and CLDN5. Survival analysis showed that PECAM1 was associated with the prognosis of LUAD. The expression of PECAM1 in tumor tissues was higher than that in normal tissues,the difference was statistically significant (P<0.05). Conclusion PECAM1 is a new biomarker related to the prognosis of lung adenocarcinoma and is expected to be a target for the treatment of lung adenocarcinoma.

参考文献/References:

[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. [2]Cho J,Choi SM,Lee J,et al.Proportion and clinical features of never-smokers with non-small cell lung cancer[J].Chin J Cancer,2017,36(1):20. [3]全斌,喻艳林.肺结核合并肺癌的发生机制研究进展[J].山东医药,2015,55(24):104-106. [4]Guo T,Ma H,Zhou Y.Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma[J].Peer J,2019(7):e7313. [5]Di X,Jin X,Li R,et al.CircRNAs and lung cancer:Biomarkers and master regulators[J].Life Sci,2019(220):177-185. [6]Vargas AJ,Harris CC.Biomarker development in the precision medicine era:lung cancer as a case study[J].Nat Rev Cancer,2016,16(8):525-537. [7]Hanna N,Johnson D,Temin S,et al.Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer:American Society of Clinical Oncology Clinical Practice Guideline Update Summary[J].J Oncol Pract,2017,13(12):832-837. [8]Piao J,Sun J,Yang Y,et al.Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis[J].Gene,2018(647):306-311. [9]高强,钟英英,丁华杰,等.肺腺癌相关基因的生物信息学分析[J].中国肿瘤生物治疗杂志,2019,26(2):190-195. [10]Rask L,Hogdall CK,Kjaer SK,et al.Association of CD31 and p53 With Survival of Ovarian Cancer Patients[J].Anticancer Res,2019,39(2):567-576. [11]Molinsky J,Klánová M,Maswabi B,et al.In vivo growth of mantle cell lymphoma xenografts in immunodeficient mice is positively regulated by VEGF and associated with significant up-regulation of CD31/PECAM1[J].Folia Biol (Praha),2013,59(1):26-31. [12]Mas VR,Maluf DG,Archer KJ,et al.Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma[J].Mol Med,2009,15(3-4):85-94. [13]袁梅琴,王增,王海洋,等.血清PECAM-1和IGF-1水平与晚期胃癌临床病理特征及预后的相关性研究[J].中华全科医学,2018(7):1051-1053. [14]Haslinger C,Schweifer N,Stilgenbauer S,et al.Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status[J].J Clin Oncol,2004,22(19):3937-3949. [15]Skrzypczak M,Goryca K,Rubel T,et al.Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability[J].PLoS One,2010,5(10):e13091. [16]Lertkiatmongkol P,Liao D,Mei H,et al.Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)[J].Curr Opin Hematol,2016,23(3):253-259. [17]Umezawa Y,Akiyama H,Okada K,et al.Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1)[J].J Biol Chem,2017,292(48):19639-19655. [18]Khan I,Bhardwaj M,Shukla S,et al.Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2,VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model[J].Colloids Surf B Biointerfaces,2019(181):612-622.

相似文献/References:

[1]刘治利,葛明建.肺部磨玻璃结节的CT特征与治疗策略进展[J].医学信息,2018,31(11):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
　LIU Zhi-li,GE Ming-jian.Advances in CT Features and Treatment Strategies of Pulmonary Ground-glass Nodule[J].Journal of Medical Information,2018,31(22):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
[2]彭玉龙,张 露,陈荣辉,等.吉西他滨与培美曲塞联合卡铂治疗晚期肺腺癌的临床观察[J].医学信息,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
　PENG Yu-long,ZHANG Lu,CHEN Rong-hui,et al.Clinical Observation of Gemcitabine and Pemetrexed Combined with Carboplatin in Treatment of Advanced Lung Adenocarcinoma[J].Journal of Medical Information,2018,31(22):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
[3]刘贤丰,李子俊.恩度联合培美曲塞与顺铂治疗晚期肺腺癌的临床效果观察[J].医学信息,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
　LIU Xian-feng,LI Zi-jun.Clinical Observation of Endo Combined with Pemetrexed and Cisplatin in the Treatment of Advanced Lung Adenocarcinoma[J].Journal of Medical Information,2019,32(22):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
[4]葛丽艳,王 琦,朱 宏,等.基于数据挖掘分析GPR35表达对肺腺癌预后的影响[J].医学信息,2018,31(23):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
　GE Li-yan,WANG Qi,ZHU Hong,et al.The Effect of GPR35 Expression on Prognosis of Lung Adenocarcinoma was Analyzed Based on Data Mining[J].Journal of Medical Information,2018,31(22):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
[5]唐怀慧,王忠帅,邵茜茜,等.基于TCGA数据库肺腺癌RNAs构建ceRNA网络的综合分析[J].医学信息,2020,33(07):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
　TANG Huai-hui,WANG Zhong-shuai,SHAO Qian-qian,et al.Comprehensive Analysis of Constructing ceRNA Network Based on TCGA Database of Lung Adenocarcinoma RNAs[J].Journal of Medical Information,2020,33(22):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
[6]莫俊贤,冼 磊.miRNA-21及PTEN在肺腺癌组织中的表达及意义[J].医学信息,2020,33(09):77.[doi:10.3969/j.issn.1006-1959.2020.09.022]
　MO Jun-xian,XIAN Lei.Expression and Significance of miRNA-21 and PTEN in Lung Adenocarcinoma[J].Journal of Medical Information,2020,33(22):77.[doi:10.3969/j.issn.1006-1959.2020.09.022]
[7]王雨娜,吴冬桂,赵 贝.基于数据挖掘AGR2在胰腺癌中的表达及预后潜力[J].医学信息,2022,35(22):9.[doi:10.3969/j.issn.1006-1959.2022.22.002]
　WANG Yu-na,WU Dong-gui,ZHAO Bei.Expression and Prognostic Potential of AGR2 in Pancreatic Cancer Based on Data Mining[J].Journal of Medical Information,2022,35(22):9.[doi:10.3969/j.issn.1006-1959.2022.22.002]
[8]李 敖,王玉然,王文浩.基于公共数据库分析自噬相关基因在肺腺癌患者中的预后意义[J].医学信息,2022,35(22):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
　LI Ao,WANG Yu-ran,WANG Wen-hao.Prognostic Significance of Autophagy-related Genes in Patients with Lung Adenocarcinoma Based on Public Database Analysis[J].Journal of Medical Information,2022,35(22):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
[9]孔德伟,吴 铭,张 岩.肺腺癌骨转移肿瘤标记物的研究进展[J].医学信息,2022,35(23):171.[doi:10.3969/j.issn.1006-1959.2022.23.038]
　KONG De-wei,WU Ming,ZHANG Yan.Research Progress on Tumor Markers of Bone Metastasis in Lung Adenocarcinoma[J].Journal of Medical Information,2022,35(22):171.[doi:10.3969/j.issn.1006-1959.2022.23.038]
[10]华 凌,季虹岑,许婧喆,等.肠息肉与早期结直肠癌基因表达谱特征差异的生物信息学分析[J].医学信息,2022,35(24):7.[doi:10.3969/j.issn.1006-1959.2022.24.002]
　HUA Ling,JI Hong-cen,XU Jing-zhe,et al.Bioinformatics Analysis of Gene Expression Profile Differences Between Intestinal Polyps and Early Colorectal Cancer[J].Journal of Medical Information,2022,35(22):7.[doi:10.3969/j.issn.1006-1959.2022.24.002]

更新日期/Last Update: 2019-11-15